Aloren (no. 127) Pty Ltd

Status: Registered
Australian Company Number: 058116680
Australian Business Number: 50058116680
Registration date: 1992-11-17
Type: Australian proprietary company
Class: Limited by Shares
Subclass: Proprietary other
last updated

Description

Aloren (no 127) Pty Ltd is a limited by shares Australian proprietary company. Located at NSW 2088 since 2000-03-04 the company is, as the updated on 2000-05-30 ABN database shows, registered. Known company numbers for Aloren (no 127) Pty Ltd are as follows: ACN - 058116680, Australian Business Number - 50058116680. Aloren (no 127) Pty Ltd is one of the trading names this company has used, to be specific, the trading names list includes 1 position that is Aloren (no 127) Pty Ltd since 2000-03-04. Their official company name changed on 2000-03-04 to Aloren (no 127) Pty Ltd. The company had used this name up until 2000-05-30.

Details for ABN 50058116680

Type: Australian Private Company

ABN Status

Status From To
Active 2000-03-04 current

Main Name

Name From To
Aloren (no. 127) Pty Ltd 2000-05-30 current
Aloren (no 127) Pty Ltd 2000-03-04 2000-05-30

Trading Names

Name From To
Aloren (no 127) Pty Ltd 2000-03-04 current

Main Location

Location From To
NSW 2088 2000-03-04 current

Advertisements

Find company

NSW 2088 Location

2024 © aubiz.net - ABN Lookup, ACN, ABR, ABN Search. All rights reserved.
Contact us: info@aubiz.net
Terms of Use and Privacy Policy

Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.